Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.
- DOI
- 10.1007/s10875-026-02010-4
- Published
- 2026 Mar 29
- Container
- Journal of clinical immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10875-026-02010-4,
title = {Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.},
author = {McDermott DH and Majumdar S and Velez D and Cho E and Li Z and Gao JL and Grieco MC and Lawrence MG and Silva SL and Castelo-Soccio LA and Follmann D and Murphy PM},
year = {2026},
journal = {Journal of clinical immunology},
doi = {10.1007/s10875-026-02010-4},
url = {https://doi.org/10.1007/s10875-026-02010-4}
}RIS
TY - JOUR TI - Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome. AU - McDermott DH AU - Majumdar S AU - Velez D AU - Cho E AU - Li Z AU - Gao JL AU - Grieco MC AU - Lawrence MG AU - Silva SL AU - Castelo-Soccio LA AU - Follmann D AU - Murphy PM PY - 2026 JO - Journal of clinical immunology DO - 10.1007/s10875-026-02010-4 UR - https://doi.org/10.1007/s10875-026-02010-4 ER -
APA
DH, M., S, M., D, V., E, C., Z, L., JL, G., MC, G., MG, L., SL, S., LA, C., D, F., & PM, M. (2026). Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.. Journal of clinical immunology. https://doi.org/10.1007/s10875-026-02010-4
Source records
- pubmed · retrieved 2026-09-25T16:48:10.644Z
- europe-pmc · retrieved 2026-09-25T16:48:10.652Z